Clinicopathological profile and surgical treatment of abdominal tuberculosis: a single centre experience in northwestern Tanzania by Phillipo L Chalya et al.
RESEARCH ARTICLE Open Access
Clinicopathological profile and surgical treatment
of abdominal tuberculosis: a single centre
experience in northwestern Tanzania
Phillipo L Chalya1*, Mabula D Mchembe2†, Stephen E Mshana3†, Peter F Rambau4†, Hyasinta Jaka5†
and Joseph B Mabula1†
Abstract
Background: Abdominal tuberculosis continues to be a major public health problem worldwide and poses
diagnostic and therapeutic challenges to general surgeons practicing in resource-limited countries. This study was
conducted to describe the clinicopathological profile and outcome of surgical treatment of abdominal tuberculosis
in our setting and compare with what is described in literature.
Methods: A prospective descriptive study of patients who presented with abdominal tuberculosis was conducted
at Bugando Medical Centre (BMC) in northwestern Tanzania from January 2006 to February 2012. Ethical approval
to conduct the study was obtained from relevant authorities. Statistical data analysis was performed using SPSS
version 17.0.
Results: Out of 256 patients enrolled in the study, males outnumbered females. The median age was 28 years
(range = 16–68 years). The majority of patients (77.3%) had primary abdominal tuberculosis. A total of 127 (49.6%)
patients presented with intestinal obstruction, 106 (41.4%) with peritonitis, 17 (6.6%) with abdominal masses and
6 (2.3%) patients with multiple fistulae in ano. Forty-eight (18.8%) patients were HIV positive. A total of 212 (82.8%)
patients underwent surgical treatment for abdominal tuberculosis. Bands /adhesions (58.5%) were the most
common operative findings. Ileo-caecal region was the most common bowel involved in 122 (57.5%) patients.
Release of adhesions and bands was the most frequent surgical procedure performed in 58.5% of cases.
Complication and mortality rates were 29.7% and 18.8% respectively. The overall median length of hospital stay was
32 days and was significantly longer in patients with complications (p < 0.001). Advanced age (age ≥ 65 years),
co-morbid illness, late presentation, HIV positivity and CD4+ count < 200 cells/μl were statistically significantly
associated with mortality (p < 0.0001). The follow up of patients were generally poor as only 37.5% of patients were
available for follow up at twelve months after discharge.
Conclusion: Abdominal tuberculosis constitutes a major public health problem in our environment and presents a
diagnostic challenge requiring a high index of clinical suspicion. Early diagnosis, early anti-tuberculous therapy and
surgical treatment of the associated complications are essential for survival.
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Background
Tuberculosis (TB) is a common and major health prob-
lem, especially in developing countries where, ignorance,
poverty, overcrowding, poor sanitation and malnutrition
are prevalent [1]. It has been declared a global emer-
gency by the World Health Organization (WHO) and is
the most important communicable disease worldwide
[2,3]. Approximately one third of the world population
is infected with tuberculosis and about three millions die
each year from this disease [1-3]. Despite increased health
standards in developed countries, the incidence of tubercu-
losis which was previously reported to be low in these
countries, is again on the rise due to the influx of immi-
grants from third world countries, increasing incidence of
human immunodeficiency virus (HIV) infection, an ageing
population, alcoholism, increased use of immunosuppres-
sive drugs, and the emergence of multi-resistant strains of
Mycobacterium tuberculosis [4,5].
Most cases of TB are caused by M. Tuberculosis and
the reservoir of infection is humans with active TB. Most
cases of TB are pulmonary and acquired by person to
person transmission of air-borne droplets of organisms.
Abdominal TB may be contracted by drinking dairy milk
contaminated with M. Bovis [6].
Tuberculosis can affect any part of the body and abdo-
men is the next common site after lungs affected by the
disease [7]. In the abdomen, tuberculosis may affect the
gastro-intestinal tract, peritoneum, lymph nodes, and
solid viscera. Approximately 1-3% of total TB cases are
extra pulmonary [8,9], of these abdominal tuberculosis
(ATB) accounts for 11%-16% [10]. In HIV positive
patients the incidence of extra pulmonary TB is up
to 50% [1,10].
The modes of infection of abdominal tuberculosis
include hematogenous spread from a primary lung focus
that reactivates later or miliary tuberculosis, spread via
lymphatics from infected nodes, ingestion of bacilli
either from the sputum or from infected sources such
as milk products, or by direct spread from adjacent
organs [11].
Whereas intestinal (enteric) tuberculosis exists in one
of the three main forms i.e. ulcerative, hypertrophic or
ulcerohypertrophic, and fibrous stricturing form [12,13],
peritoneal involvement (TB peritonitis) exists in four
main forms namely ascitic, loculated (encysted), plastic
(fibrous) and purulent forms [12]. The lymph nodes in
the small bowel mesentery and the retroperitoneum are
commonly involved, and these may caseate and calcify
[13]. Disseminated abdominal tuberculosis involving the
gastrointestinal tract, peritoneum, lymph nodes and
solid viscera has also been described [11-13].
The diagnosis of abdominal TB in initial stages is
difficult as the clinical features are vague, diverse and
there is no specific diagnostic test [7,12,13]. It remains a
considerable diagnostic challenge, especially in the
absence of pulmonary infection, as the disease can
mimic various gastrointestinal disorders, particularly the
inflammatory bowel disease, colonic malignancy, or other
gastrointestinal infections [7,12].
Abdominal tuberculosis is characterized by different
modes of presentation, viz, chronic, acute and acute-
on-chronic, or it may be an incidental finding at
laparotomy for other diseases [14]. The clinical presentation
depends upon the site and type of involvement. It
usually runs an indolent course and presents late with
complications especially acute or sub-acute intestinal
obstruction due to mass (tuberculoma) or stricture
formation in small gut and ileocaecal region or gut
perforation leading to peritonitis [15].
The management of abdominal TB poses diagnostic
and therapeutic challenges to general surgeons prac-
ticing in resource-limited countries such as Tanzania
[1,12]. Late presentation of the disease coupled with
ignorance, poverty, overcrowding, poor education,
malnutrition and lack of modern diagnostic and
therapeutic facilities are among the hallmarks of the
disease in these countries. Despite advances in medical
imaging, the early diagnosis of abdominal tuberculosis
is still a problem and patients usually present when
complications had occurred.
The treatment of abdominal tuberculosis is mainly
conservative (non-operatively) with anti-tuberculous
therapy and surgical treatment is reserved for complications
such as intestinal obstruction and bowel perforation with
peritonitis [12,16].
Despite the fact that abdominal tuberculosis and its
complications is prevalent in our environment, little
work on this subject has been done in Tanzania and the
study area in particular. This study was conducted to
describe the clinicopathological profile and outcome
of surgical treatment of abdominal tuberculosis in our
setting and compare with what is described in literature.
Methods
Study area and design
A prospective descriptive study of patients who presented
to Bugando Medical Centre (BMC) with a clinical diagnosis
of abdominal tuberculosis was conducted from January
2006 to February 2012. BMC is located in Mwanza city
along the shore of Lake Victoria in the northwestern
part of Tanzania. It is a 1000-bed, tertiary care and
teaching hospital for the Catholic University of Health
and Allied Sciences-Bugando (CUHAS-Bugando) and
other paramedics. BMC is one of the four largest
referral hospitals in the country and serves as a referral
centre for tertiary specialist care for a catchment
population of approximately 13 million people from
neighboring regions.
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Study population and selection criteria
During the period of study, all patients who presented to
BMC with clinical diagnosis of abdominal tuberculosis
were consecutively enrolled into the study after a written
informed consent to participate in the study and for
HIV testing. Abdominal tuberculosis was defined as M.
tuberculosis infections involving the gastrointestinal
tract, peritoneum, or intra-abdominal solid organs [8,9].
Patients who failed to give proper history and those
without next of kin to consent for the study were ex-
cluded from the study. Patients who failed to consent for
HIV infection testing were also excluded from the study.
They had been admitted either to the surgical, medical,
pediatric or emergency department according to the age
and clinical presentation. The criteria for diagnosis of
abdominal tuberculosis were clinical suspicion, labora-
tory findings, operative findings, proven histologically,
demonstration of AFB and response to anti-tuberculosis
drugs. In all cases, assessment was done by detailed his-
tory and physical examination and relevant investiga-
tions. Relevant preoperative investigations included
hemoglobin levels, packed cell volume, serum electro-
lytes, urea and creatinine, blood grouping and cross-
matching and ESR. Patients were also screened for HIV
testing using Tanzania HIV Rapid Test Algorithm [17]
and CD 4+ count using FACS or FACSCALIBUR from
BD Biosciences USA. A determination of CD 4 count
was only performed in HIV positive patients. Radio-
logical investigations included Chest X-ray, abdominal
X- ray and abdominal ultrasonography. Patients with
normal chest X- rays but had symptoms and signs of ab-
dominal tuberculosis were considered to have primary
abdominal tuberculosis. Abdominal ultrasound and CT
scan were also performed in some patients suspected to
have associated abdominal collections or masses.
All patients were treated either surgically or non-
surgically by anti tuberculosis therapy. The operations
were performed either by a consultant surgeon or a se-
nior resident under the direct supervision of a consult-
ant surgeon. Intraoperative tissue biopsy was taken for
histopathological studies; a portion of the tissue was
fixed in 10 per cent formalin; routine processing was
done as per standard operative procedures and stained
with haemotoxylin and eosin. Presence of caseating
granulomas surrounded by epitheloid cells, lymphocytes,
plasma cells and giant cells were diagnostic of tubercu-
losis [18,19]. Post-operatively patients were kept nil or-
ally till return of bowl sounds and at that time
nasogastric tubes were removed. Final diagnosis and
postoperative treatment was dependent on the operative
findings and histopathological confirmation. Those
found to be tuberculous were started on anti tubercu-
losis therapy according to the Tanzania National Tuber-
culosis and Leprosy Programme (NTLP) [20]. The anti
tuberculosis therapy given included Isoniazid, Rifampicin,
Pyrazinamide, Ethambutol and Streptomycin. All patients
had been managed by medical and surgical teams.
Data on each patient were entered into a pro forma
prepared for the study. The study variables included
socio-demographic (i.e. age and sex, level of education,
occupation and area of residence), clinical presentation,
HIV status, radiological findings, timing of surgical
procedure, operative findings and surgical procedure
performed. The variables studied in the postoperative
period were postoperative complications, hospital stay
and mortality. Patients were followed up for a period of
twelve months or till death whichever is earlier.
Statistical data analysis
The statistical analysis was performed using statistical
package for social sciences (SPSS) version 17.0 for
Windows (SPSS, Chicago IL, U.S.A).The median +
Interquartile Range (IQR) and ranges were calculated
for continuous variables whereas proportions and fre-
quency tables were used to summarize categorical variables.
Chi-square (χ2) test were used to test for the significance of
association between the independent (predictor) and
dependent (outcome) variables in the categorical variables.
The level of significance was considered as p < 0.05. Study
variable that was found to be statistically significant in
univariate analysis were subjected to multivariate logistic
regression analysis. Multivariate logistic regression analysis
was used to determine predictor variables that predict the
postoperative complications, hospital stay and mortality.
Ethical consideration
Ethical approval to conduct the study was obtained from
the CUHAS-Bugando/BMC joint institutional ethic
review committee before the commencement of the
study. Patients were required to sign a written informed
consent for the study and for HIV testing.
Results
Socio-demographic profile
Out of 256 patients enrolled in the study, 148 (57.8%)
were males and 108 (42.2%) were females with a male to
female ratio of 1.4: 1. The age of patients ranged from
16 to 68 years with a median age of 28 (IQR = 22 to 38)
years. The modal age group was 21–30 years (Figure 1).
The majority of patients, 211 (82.4%) had either primary
or no formal education and more than eighty percent of
them were unemployed. The majority of patients, 198
(77.3%) came from poor families in the rural areas
located a considerable distance from the study area.
More than ninety percent of our study patients had no
identifiable health insurance.
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Clinical presentation of patients with abdominal
tuberculosis
Generally, the duration of illness prior to admission in
this study varied from 2 days to 3 years with a median of
6 (IQR = 4 to 10) months. The majority of patients, 152
(59.4%) had symptoms of more than 6 months duration
at the time of presentation. The commonest presenting
symptom was abdominal pain in 240 (93.8%) patients as
shown in Table 1. The most common mode of presenta-
tion was acute in 182 (71.1%) patients, followed by sub-
acute and chronic presentation in 47 (18.4%) and 27
(10.5%) patients respectively. A total of 127 (49.6%)
patients presented with intestinal obstruction, 106 (41.4%)
with peritonitis, 17 (6.6%) with abdominal masses and 6
(2.3%) patients with multiple fistulae in ano. Co-existing
medical illness was recorded in 15 (5.9%) patients. This
included diabetes mellitus in five patients, liver cirrhosis
in three patients, cancer, hypertension and chronic renal
failure in two patients each respectively and toxic goiter in
one patient. Forty-eight (18.8%) patients were HIV
positive. Of these, 16 (33.3%) patients were known cases
on ant-retroviral therapy (ARV) and the remaining 32
(66.7%) patients were newly diagnosed patients. Out of 48
HIV positive patients, 37 (77.1%) had risk factors for HIV
infection such as multiple sexual partners (Odd Ratio
4.56, C.I. (2.98- 6.40), p = 0.001) and alcoholism (Odds
Ratio 3.51, C.I. (2.17- 12.39), p = 0.011). Past history of
treatment for tuberculosis was present in 18 (7.0%)
patients and a family history of tuberculosis was found in
9 (3.5%) patients. The majority of patients, 198 (77.3%)
had primary abdominal tuberculosis and the remaining 58
(22.7%) patients had associated pulmonary tuberculosis
(secondary abdominal tuberculosis).
Laboratory, radiological and histological investigations
The median hemoglobin level and ESR were 8.0 (IQR = 4
to 10 g/dl) (range = 4.2-12.6 g/dl) and 56 mm/hour
(IQR = 34 to 78mm/hour) (range=32- 145mm/hour)
respectively. The hemoglobin level was less than 10
g/dl in 211 (82.4%) patients. Serum creatinine and
electrolytes were performed in all patients and revealed
low results in 102 (39.8%) and 67 (26.2%) patients respect-
ively. Serological test for HIV infection revealed positive
results in forty-eight (18.8%) patients. CD 4+ count was
available only in thirty-two patients and their median CD
4+ count was 216 cells/μl (IQR = 154 to 562 cells/μl)
(range 54–640 cells/μl). A total of eighteen (56.3%) HIV
Figure 1 Distribution of patients according to age group.
Table 1 Distribution of patients according to clinical
presentation
Clinical presentation Frequency Percentage
Abdominal pain 240 93.8
Vomiting 204 79.7
Constipation 165 64.5
Weight loss 122 47.7
Abdominal distention 94 36.7
Fever 86 33.6
Diarrhea/constipation 78 30.5
Features of peritonism 70 27.3
Abdominal tenderness/muscle guarding 70 27.3
Abdominal mass 17 6.6
Perianal abscess 6 2.3
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patients had CD4+ count below 200 cells/μl and
remaining 14 (43.7%) patients had CD4+ count of
≥200 cells/μl. No acid-fast bacilli culture of the ascetic fluid
was performed. Plain radiography of the abdomen revealed
multiple dilated loops of small gut with significant air-fluid
levels in erect films in 120 (46.9%) patients. Free air under
the right dome of diaphragm was seen in 76 (29.7%)
patients. Features suggestive of pulmonary tuberculosis on
chest x-rays were found in 58 (22.7%) patients and 12
(4.7%) had radiological features of active pulmonary
tuberculosis. Abdominal ultrasound and computed
tomography (CT) scan were performed in 142 (55.5%)
and 23 (9.0%) patients respectively and revealed abnormal
findings suggestive of abdominal TB such as ascites,
enlarged lymph nodes, omental thickening, bowel wall
thickness and abdominal masses. According to abdominal
ultrasound, 34 patients had ascites with fibrinous strands
seen in ascitic fluid in 25 (73.5%) patients. Barium studies
were performed in 72 (28.1%) patients and common
features suggestive of abdominal TB were luminal
narrowing with proximal dilatation of bowel loops.
Histological examination on biopsy specimen was done in
221(86.3%) patients and revealed presence of non caseating
granuloma in 138 (53.9%) patients, central caseation in 56
(21.9%) patients and chronic inflammatory cells infiltration
with no definite granuloma in 27 (10.5%) patients. In
thirty-five (13.7%) patients with suggestive clinical history
and negative diagnostic workup, response to therapeutic
trial of anti TB drugs was the basis of diagnosis. In
this study, no patient had colonoscopic investigation
for intestinal TB. The use of Polymerase Chain Reaction
(PCR) to detect M. tuberculosis in abdominal tuberculosis
was not performed in any of our patients.
Admission pattern among patients with abdominal
tuberculosis
In this study, two hundred and twenty-four (87.5%)
patients were admitted to the general surgical wards.
The remaining thirty-two (12.5%) patients were treated as
out-patients.
Operative findings, sites of abdominal TB involvement
and treatment modalities
A total of 212 (82.8%) patients underwent surgical
treatment for abdominal tuberculosis and the remaining
44 (17.2%) patients were treated conservatively with
antituberculous therapy. Of those who underwent
surgery, 182 (85.8%) were operated on emergency basis
while 30 (14.2%) patients had an elective surgery due to
failure to resolve with conservative management (i.e.
poor response to therapeutic trial of antituberculous
drugs). Patients who failed to respond to therapeutic
trial of ant-tuberculous drugs underwent surgery and
tissue diagnosis was established of tuberculosis in all 30
patients. Operative findings of abdominal tuberculosis
are depicted in Table 2. The site of abdominal TB
involvement was intestinal in 127 (49.6%), peritoneal in
106 (41.4%), nodal in 10 (3.9%) and solid viscera in 7
(2.7%) patients. The remaining 6 (2.3%) patients had
multiple perianal fistulae (Figure 2).
Ileo-caecal region was the most common bowel
involved in 122 (57.5%) patients, followed by ileum
and jejunum in 72 (34.0%) and 12 (5.7%) patients
respectively. The colon was involved in 6 (2.8%)
patients. Release of bands and adhesions was the
most frequent surgical procedure performed in 58.5%
of cases (Table 3). Postoperatively all the patients
were required to take anti-tuberculous drugs for a period
of one year. Patients receiving anti-tuberculous therapy
had 4 weekly follow-ups.
Treatment outcome and follow up of patients
A total of 124 postoperative complications were recorded
in 76 (29.7%) patients, of which surgical site infection (SSI)
was the most common complication accounting for 37.1%
of cases (Table 4). Surgical site infection was statistically
significantly associated with HIV positivity (p= 0.004) and
low CD 4+ count p = 0.000).
The overall length of hospital stay (LOS) ranged from
1 to 126 days with a median of 32 days (IQR = 16 to 54
days. The LOS for non-survivors ranged from 1–14 days
with a median of 6 days (IQR = 3 to 8days. Patients who
had post complications stayed longer in the hospital and
this was statistically significant (P = 0.022).
A total of 48 (18.8%) patients died. According to
multivariate logistic regression analysis, advanced age
(≥ 65 years old) (OR = 6.7, 95% CI (2.2- 11.4), p = 0.011),
co-morbid illness (OR = 11.1, 95% C.I. (7.1- 14.9),
p = 0.021), late presentation (OR = 10.3, 95% CI (8.1- 12.8),
P = 0.029), HIV positivity (OR = 11.4, 95% CI (9.1- 17.9),
p = 0.001), low CD 4 count (<200 cells/μl) (OR = 3.8,
Table 2 Distribution of patients according to operative
findings (N=212)
Operative findings Frequency Percentages
Bands and adhesions 124 58.5
Strictures 78 36.8
Purulent peritonitis 76 35.8
Bowel perforations 32 15.1
Gross adhesions 26 12.3
Ileo-caecal mass 14 6.6
Enlarged mesenteric lymph nodes with
adherent small bowel
10 4.7
Splenic /hepatic mass 7 3.3
Appendicular perforation 6 2.8
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95%CI (1.3-15.9), p = 0.000) were statistically significantly
associated with mortality.
Follow up of patients
Out of two hundred and eight survivors, 188 (90.4%)
patients were discharged well. Twenty (9.6%) patients
were discharged against medical advice. No patient in the
present study reported to have permanent disabilities. Of
the 208 survivors, only 78 (37.5%) patients were available
for follow up at twelve months after discharge and the
remaining 130 (62.5%) patients were lost to follow up. No
patient showed a relapse of disease during this follow-up
period. However six patients developed drug induced
hepatitis which all of them recovered with modification of
drug therapy.
Discussion
Abdominal tuberculosis constitutes a major public health
problem in developing countries and carries significant
morbidity and mortality [1,2,12]. In this review, males were
slightly more affected than females, an observation which is
in accordance with the results of other workers [14,21].
Other authors have reported female predominance [22-25].
Some authors report that the disease is more common in
males in the western countries while in developing
counties the females predominate [26]. We could not
find in literature the reasons for this gender differences.
Abdominal Tuberculosis can affect any age group but
is more common in young people at the peak of their
productive life [27]. This is reflected in this study as
majority of our patients were in the second and third
decades of life, which is consistent with other studies
[14,28]. The presentation of abdominal tuberculosis in
this age group has great economic impact since these
are people in their most productive years and this
disease imposes a considerable burden on their families
and the society as a whole.
In agreement with other studies [12,29-31], the major-
ity of patients inches study came from poor families in
the rural areas located a considerable distance from the
study area and more than ninety percent of them had no
identifiable health insurance. This observation has an
implication on accessibility to health care facilities and
awareness of the disease.
In keeping with other authors [30-32], the majority of
our patients in this study had symptoms of more than 6
months duration at the time of presentation. The
reasons for late presentation in this study may be
Figure 2 Distribution of patients according to the type of abdominal TB.
Table 3 Distribution of patients according to the type of
surgical procedure performed (N = 212)
Type of surgical procedures Frequency Percentage
Release of bands and adhesions 124 58.5
Segmental bowel resection with end to end
anastomosis
56 26.4
Right hemicolectomy with ileo-transverse
anastomosis
14 6.6
Repair of bowel perforation 12 5.7
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attributed to the fact that the diagnosis of abdominal TB
in its initial stages is usually difficult due to vague
and non-specific symptoms as a result patients
remain undiagnosed and subsequently present late
with complications such as intestinal obstruction and
bowel perforation with peritonitis. Late presentation
in this study may also be attributed to lack of accessibility
to health care facilities, lack of awareness of the disease as
a result some patients with tuberculous intestinal
obstruction may decide to take medications in the
pre-hospital period with hope that the symptoms
will abate. It is also possible that some clinicians
managing the patients initially may not have considered as
a possible diagnosis. In resource-poor countries like
Tanzania, difficulties in diagnosis of abdominal TB, patient
transfer, and inadequate medical treatment often result in
delayed presentation to a hospital.
In our study, majority of patients were having acute
presentation and were admitted through emergency
department with intestinal obstruction and peritonitis
requiring emergency exploratory laparotomy. Other
authors have also reported similar observations [25,33].
The presence of large number of patients with intestinal
obstruction and peritonitis in our series may be
attributed to diagnostic delay of abdominal TB leading to
development of complications such as intestinal
obstruction and peritonitis as a result of bowel perforations.
Anal tuberculosis (tuberculous anal fistulae) has been
reported to be less uncommon and has a distinct clinical
presentation. Tubercular fistulae are usually multiple and
recurrent [33-36]. Shukla et al. [37] reported that tubercu-
losis accounted for up to 14 per cent of cases of fistula in
ano. In our study, fistula in ano was reported in only 2.3%
of cases and all of them were multiple.
The majority of patients in this study had primary
abdominal tuberculosis and only 22.7% of patients had
associated pulmonary tuberculosis (secondary abdominal
tuberculosis). The high prevalence of primary intestinal
tuberculosis in the present series is in accordance with
most of the other studies conducted in developing
countries [14,25,38]. Studies from developed countries
have shown secondary tuberculosis to be more
common [39]. We could not establish the reasons for
this geographical variation.
The presence of co-existing medical illness has been
reported elsewhere to have an effect on the outcome
of patients with tuberculous intestinal obstruction
[40]. This is reflected in our study where patients
with co-existing medical illness had significantly high
mortality rate.
In this study, HIV seroprevalence was found to be
18.8%, a figure that is significantly higher than that in
the general population in Tanzania (6.5%) [41]. High
HIV seroprevalence in our study may be attributed to
high percentage of the risk factors for HIV infection
reported in our study population. However, failure to
detect HIV infection during window period and
exclusion of some patients from the study may have
underestimated the prevalence of HIV infection among
these patients. HIV infection has been reported to
increase the risk of surgical site infection and mortality
[42]. In our study, the rate of surgical site infections and
mortality was found to be significantly higher in HIV
positive patients than in non HIV patients.
Radiological investigation is the mainstay in making
presumptive diagnosis of abdominal TB, this include
chest x-rays, ultrasound or CT scan of the abdomen
and barium studies [43,44]. Of all the radiological
investigations, CT scan of the abdomen, which is a
costly investigation, gives a better view of intestinal
and extra intestinal structures. However, in this
review, CT scan of the abdomen was done in only
9.0% of patients, which is in keeping with other
studies [45,46]. This was attributed to irregular availability
of CT scan due to breakdown or inability of patients to
afford. Diagnosis made on the basis of radiology is rapid,
easy and less expensive but it is presumptive and cannot
exclude completely other diseases like Crohn’s disease and
malignancies of solid abdominal viscera [47].
Demonstrating tuberculous granuloma is probably the
most important investigation for a definitive diagnosis of
abdominal tuberculosis. In our study, histopathology was
the basis of diagnosis in 86.3% of patients; however a
typical granuloma with caseation was found only in
21.9% of patients in our series. Similar histopathological
pattern was reported by Khan et al. [48]. The yield
of demonstrating tuberculous granuloma has been
reported to be high when the specimen is taken
surgically or through laparoscopy than when it is
taken colonoscopically. On colonoscopic biopsies, if
granuloma is non-caseating, interpretation is difficult
because Crohn’s disease cannot be excluded [45].
Many authors advocated therapeutic trial with anti
tubercular therapy but it should not be encouraged
routinely as it may delay the diagnosis of malignancy,
lymphoma and Crohn’s disease [45,49]. In the present
Table 4 Distribution of patients according to
postoperative complications (N = 124)
Postoperative complication Frequency Percentages
Surgical site infections 46 37.1
Paralytic ileus 12 9.7
Enterocutaneous fistula 10 8.1
Intraabdominal abscess/ peritonitis 8 6.5
Wound dehiscence/ burst abdomen 6 4.8
Keloids 5 4.0
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study, response to therapeutic trial of anti TB drugs was
the basis of diagnosis in 13.7% of patients with suggest-
ive clinical history and negative diagnostic workup. This
figure is high than 2.0% reported by Khan et al. [48].
In the literature up to 40% of patients were given
therapeutic trial of anti TB drugs [46].
In keeping with other reports [14,32,48,49], intestinal TB
was the most predominant form of abdominal TB in this
series and accounted for 49.6% of patients. The majority of
patients in this review had ileocaecal region involvement.
This is in agreement with other reviews on abdominal
tuberculosis in which intestinal type of abdominal tubercu-
losis ranged from 50%-78% [48,50]. It is postulated that
ileocaecal involvement is due to either physiological stasis,
large surface area of this part of the intestine, complete
digestion of food and abundant lymph nodes in the region
[11]. It has been shown that the M cells associated with
Peyer’s patches can phagocytes BCG bacilli [51].
Bands and adhesions were the most common operative
findings in this study. Similar operative findings were
reported by Ali et al. [52], but in sharp contrast to other
authors who reported bowel strictures as the most frequent
intra-operative findings [31,32].
In our series, release of bands and adhesions was the
most frequent surgical procedure performed followed by
segmental bowel resection with end to end anastomosis.
Similar surgical treatment pattern was reported by other
writers also [25,52]. This is in contrast to that reported by
Akbar et al. [32] who reported stricturoplasty as the most
common surgical procedure performed. As reported
by others [31,32,48,52], anti-tuberculous therapy was
prescribed in all the tubercular patients postoperatively.
In agreement with other studies [25,30], surgical site
infection was the commonest postoperative complications
in the present study attributing this to HIV seropositivity
and low CD 4 count.
In this study, the overall median duration of hospital stay
was 32 days which is higher than that reported by other
authors [30-32]. This can be explained by the presence of
large number of patients with postoperative complications
in our study. However, due to the poor socio-economic
conditions in Tanzania, the duration of inpatient stay for
our patients may be longer than expected.
Our mortality rate of 18.8% was significantly higher
than that reported by other authors [30,48]. High
mortality rate was reported in patients with advanced
age, co-morbid illness, HIV positivity with low CD 4
count and those who presented late to the hospital.
Addressing these factors responsible for high mortality in
our patients is mandatory to be able to reduce mortality
associated with this disease.
Discharge against medical advice is a recognized
problem in our setting. Similarly, poor follow up visits
after discharge from hospitals remain a cause for concern.
In this study, the follow up of our patients was generally
poor as more than sixty percent were lost to follow up.
These issues are often the results of poverty, long distance
from the hospitals and ignorance. Delayed presentation,
lack of theatre space, delayed histopathological confirm-
ation of abdominal tuberculosis and the large number of
loss to follow up was the major limitations in this study.
However, despite these limitations, the study has pro-
vided local data that can be utilized by health care providers
to plan for preventive strategies as well as establishment of
management guidelines for these patients. The challenges
identified in the management of patients with abdominal
tuberculosis in our environment need to be addressed, in
order to deliver optimal care for these patients.
Conclusion
Abdominal tuberculosis constitutes a major public health
problem in our environment and presents a diagnostic
challenge requiring a high index of clinical suspicion.
Young age at presentation, delayed presentation,
poverty and high morbidity and mortality are among
the hallmarks of the disease in this region. These
challenges need to be addressed in order to deliver
optimal care for these patients. Early diagnosis, early
antituberculous therapy and surgical treatment of the
associated complications are essential for survival.
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